Hepatotoxicity in patients with solid tumors treated with PD-1/PD-L1 inhibitors alone, PD-1/PD-L1 inhibitors plus chemotherapy, or chemotherapy alone: systematic review and meta-analysis

被引：0
|
作者：
Xiaodi Guo
Wendong Li
Jiexuan Hu
Emily C. Zhu
Qiang Su
机构：
[1] Capital Medical University,Department of Oncology, Beijing Ditan Hospital
[2] Capital Medical University,Department of Oncology, Beijing Friendship Hospital
[3] Texas State University,Department of CIS & Quantitative Methods, McCoy College of Business
来源：
European Journal of Clinical Pharmacology | 2020年 / 76卷
关键词：
Hepatotoxicity; PD-1/PD-L1 inhibitors; Chemotherapy; Meta-analysis; Solid tumors;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1345 / 1354
页数：9
相关论文
共 50 条
  • [1] Hepatotoxicity in patients with solid tumors treated with PD-1/PD-L1 inhibitors alone, PD-1/PD-L1 inhibitors plus chemotherapy, or chemotherapy alone: systematic review and meta-analysis
    Guo, Xiaodi
    Li, Wendong
    Hu, Jiexuan
    Zhu, Emily C.
    Su, Qiang
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 76 (10) : 1345 - 1354
  • [2] Combinations of Chemotherapy and PD-1/PD-L1 Inhibitors in Sarcoma
    Meghan M. Lynch
    Borislav A. Alexiev
    Brett A. Schroeder
    Seth M. Pollack
    Current Treatment Options in Oncology, 2022, 23 : 1861 - 1876
  • [3] Combinations of Chemotherapy and PD-1/PD-L1 Inhibitors in Sarcoma
    Lynch, Meghan M.
    Alexiev, Borislav A.
    Schroeder, Brett A.
    Pollack, Seth M.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2022, 23 (12) : 1861 - 1876
  • [4] PD-1/PD-L1 inhibitors
    Sunshine, Joel
    Taube, Janis M.
    CURRENT OPINION IN PHARMACOLOGY, 2015, 23 : 32 - 38
  • [5] Effectiveness and safety of PD-1/PD-L1 inhibitors in the treatment of solid tumors: a systematic review and meta-analysis
    Wang, Xiaohui
    Bao, Zhengqiang
    Zhang, Xiaoju
    Li, Fei
    Lai, Tianwen
    Cao, Chao
    Chen, Zhihua
    Li, Wen
    Shen, Huahao
    Ying, Songmin
    ONCOTARGET, 2017, 8 (35) : 59901 - 59914
  • [6] Efficacy of PD-1 or PD-L1 inhibitors and PD-L1 expression status in cancer: meta-analysis
    Shen, Xian
    Zhao, Bin
    BMJ-BRITISH MEDICAL JOURNAL, 2018, 362
  • [7] The predictive value of PD-L1 expression in patients with advanced hepatocellular carcinoma treated with PD-1/PD-L1 inhibitors: A systematic review and meta-analysis
    Yang, Yao
    Chen, Dongbo
    Zhao, Bigeng
    Ren, Liying
    Huang, Rui
    Feng, Bo
    Chen, Hongsong
    CANCER MEDICINE, 2023, 12 (08): : 9282 - 9292
  • [8] Programmed Cell Death 1 (PD-1) Ligand (PD-L1) Expression in Solid Tumors As a Predictive Biomarker of Benefit From PD-1/PD-L1 Axis Inhibitors: A Systematic Review and Meta-Analysis
    Khunger, Monica
    Hernandez, Adrian V.
    Pasupuleti, Vinay
    Rakshit, Sagar
    Pennell, Nathan A.
    Stevenson, James
    Mukhopadhyay, Sanjay
    Schalper, Kurt
    Velcheti, Vamsidhar
    JCO PRECISION ONCOLOGY, 2017, 1 : 1 - 15
  • [9] PD-L1 expression and PD-1/PD-L1 inhibitors in breast cancer
    Monneur, Audrey
    Goncalves, Anthony
    Bertucci, Francois
    BULLETIN DU CANCER, 2018, 105 (03) : 261 - 272
  • [10] Cardiovascular Toxicity With PD-1/PD-L1 Inhibitors in Cancer Patients: A Systematic Review and Meta-Analysis
    Liu, Surui
    Gao, Wei
    Ning, Yan
    Zou, Xiaomeng
    Zhang, Weike
    Zeng, Liangjie
    Liu, Jie
    FRONTIERS IN IMMUNOLOGY, 2022, 13
12345